Pharming focuses on the development of innovative therapeutics for significant medical needs.
80 1% Last mo
No Known Funding
Use Pharming Group's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Pharming Group's historical monthly uniques as a proxy for mindshare and web traction.
Use Pharming Group's historical Twitter followers and likes to better understand their social media traction over time.
Use Pharming Group's historical Linkedin followers to better understand their social media traction over time.
Use Pharming Group's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks
Pharming Announces Further Conversion of its Ordinary Convertible Bonds
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks
Pharming Group Reports Financial Results for the First Nine Months of 2017
Pharming Group N.V. and HAEi International Patient Organization Announce Partnership with Inceptua Medicines Access for "HAEi Global Access Program"